EP Biocomposites Ltd
₹ 126
-1.56%
16 Oct
- close price
About
Incorporated in 2020, EP Biocomposites Ltd manufactures fibre reinforced polymer products and provides bio toilet solutions[1]
Key Points
- Market Cap ₹ 21.2 Cr.
- Current Price ₹ 126
- High / Low ₹ 230 / 98.0
- Stock P/E 20.6
- Book Value ₹ 63.0
- Dividend Yield 0.00 %
- ROCE 14.3 %
- ROE 10.2 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.4% over last 3 years.
- Company has high debtors of 330 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 3m | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
0.57 | 2.95 | 8.06 | 7.12 | 11.43 | 12.01 | |
0.53 | 2.49 | 6.66 | 6.15 | 10.02 | 10.23 | |
Operating Profit | 0.04 | 0.46 | 1.40 | 0.97 | 1.41 | 1.78 |
OPM % | 7.02% | 15.59% | 17.37% | 13.62% | 12.34% | 14.82% |
0.00 | 0.00 | 0.02 | 0.17 | 0.30 | 0.11 | |
Interest | 0.00 | 0.00 | 0.19 | 0.23 | 0.04 | 0.36 |
Depreciation | 0.00 | 0.00 | 0.07 | 0.10 | 0.10 | 0.11 |
Profit before tax | 0.04 | 0.46 | 1.16 | 0.81 | 1.57 | 1.42 |
Tax % | 25.00% | 23.91% | 31.03% | 28.40% | 26.75% | 27.46% |
0.03 | 0.36 | 0.81 | 0.58 | 1.15 | 1.03 | |
EPS in Rs | 6.00 | 72.00 | 6.88 | 3.45 | 6.84 | 6.13 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 84% |
3 Years: | 14% |
TTM: | 5% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 103% |
3 Years: | 8% |
TTM: | -10% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -24% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 11% |
Last Year: | 10% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Equity Capital | 0.05 | 0.05 | 1.18 | 1.68 | 1.68 | 1.68 |
Reserves | -0.02 | 0.34 | 0.82 | 6.73 | 7.88 | 8.91 |
0.00 | 0.00 | 4.11 | 1.28 | 1.80 | 2.98 | |
0.52 | 0.94 | 3.16 | 2.03 | 3.72 | 3.06 | |
Total Liabilities | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 |
0.00 | 0.00 | 0.41 | 0.33 | 0.33 | 0.23 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.14 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.55 | 1.33 | 8.86 | 11.39 | 14.61 | 16.26 | |
Total Assets | 0.55 | 1.33 | 9.27 | 11.72 | 15.08 | 16.63 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
0.12 | 0.03 | -4.28 | -0.79 | -1.24 | -0.49 | |
0.00 | 0.00 | -0.47 | 0.02 | -0.16 | 0.02 | |
0.00 | 0.00 | 4.76 | 2.81 | 0.49 | 0.82 | |
Net Cash Flow | 0.12 | 0.03 | 0.01 | 2.04 | -0.92 | 0.35 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|
Debtor Days | 192.11 | 80.42 | 321.53 | 300.41 | 287.40 | 330.05 |
Inventory Days | 83.65 | 90.25 | 86.83 | 90.58 | 50.13 | 66.66 |
Days Payable | 349.79 | 128.35 | 161.90 | 104.79 | 143.08 | 97.87 |
Cash Conversion Cycle | -74.04 | 42.32 | 246.47 | 286.20 | 194.45 | 298.85 |
Working Capital Days | -57.63 | 25.98 | 156.69 | 255.81 | 217.47 | 270.79 |
ROCE % | 219.05% | 41.54% | 13.16% | 15.30% | 14.28% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
3 Oct - EP Biocomposites AGM Sept 30, 2025: audited financials adopted; three director appointments/reappointments; related-party industrial plot purchase approved.
- Shareholder Meeting / Postal Ballot-Outcome of AGM 30 Sep
- Closure of Trading Window 30 Sep
-
Chairman''s Speech To Be Delivered At The 6Th Annual General Meeting
29 Sep - Chairman AGM speech (Sep 30, 2025): updates, tech tie-ups, seek approval to acquire industrial assets.
-
Reg. 34 (1) Annual Report.
8 Sep - AGM Sep 30, 2025: reappoint Leena Kamat; appoint two independent directors; approve related-party property purchase up to INR 5.5 Crore.
Business Overview:[1]
a) EPBL is a flagship entity of EP Kamat
Group.
b) It manufactures and supplies Fibre
Reinforced Polymers (FRP) products
such as Door Shutters, Frames, Laminated
Doors, Biodigester Tanks, Bio Toilets and
Allied Products for Construction and Industrial applications
c) Company has an Aqua Division which offers Sewage & Effluent Treatment Plants for Hotels, Industry, Institutions, Government bodies as well as residential and commercial buildings
d) In FY24, company has added the line
of Fire doors to its portfolio